Trump Signs Psychedelic Drugs Order. 4 Stocks That Are Surging.

Barrons — Apr 20, 12:18 PM

AtaiBeckley and Compass Pathways are two drugmakers developing psychedelic treatments for depression.

Read full article at Barrons →

Trump's psychedelics executive order

Compass Pathways CEO on Trump's Order to Expand Psychedelics Research Bloomberg — Apr 20, 21:49 PM
FDA's Makary on Trump EO to Ease Access to Psychedelics Bloomberg — Apr 20, 21:14 PM
Trump’s order on psychedelics could have far-reaching science consequences Scientific American — Apr 20, 20:15 PM
How Trump's psychedelics executive order could unlock stalled cannabis reform CNBC — Apr 20, 18:05 PM
Trump administration moves forward with certain drug reclassifications CBS News — Apr 20, 15:44 PM